Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

308 Views

C5. Respiratory infections - bacterial

Poster Session: Respiratory Infections - Bacterial

(P-650) In vitro Activity of Cefiderocol and Comparator Agents Against Global Enterobacterales Isolates From Hospitalized Patients with Pneumonia Collected as Part of the SENTRY Surveillance Program (2020-2022)

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Jason J. Bryowsky, PharmD, MS

Director, Field Microbiology
Shionogi Inc.
Florham Park, New Jersey, United States

Boudewijn L. DeJonge, PhD (he/him/his)

Director Microbiology
Shionogi Inc.
Florham Park, New Jersey, United States
Sean T. Nguyen, PharmD

Director, Medical Affairs
Shionogi Inc.
Florham Park, New Jersey, United States
JM

Joshua Maher, PhD

Research Scientist
JMI Laboratories
North Liberty, Iowa, United States
Rodrigo E. Mendes, PhD (he/him/his)

Director of Microbiology & Molecular Biology
JMI Laboratories
North Liberty, Iowa, United States
CL

Christopher M. Longshaw, PhD

Senior Director, Scientific Affairs EU
Shionogi B.V.
London, England, United Kingdom
MT

Miki Takemura, n/a

Director, Head of Infectious Diseases 5, Laboratory for Drug Discovery and Disease Research
Shionogi & Co., Ltd
Toyonaka, Osaka, Japan
Yoshinori Yamano, PhD (he/him/his)

Chief Scientific Officer for Infectious Diseases
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan